ARCHIVES

DRG Reimbursement Schedules Estimated for High, Low Areas; City Of Hope Added to Exemptions, Other Without Much Hope

This article is from The Cancer Letter archive.

Vol. 09 No. 44 | November 18, 1983

Download PDF Visit The Full Archive

Related Articles

Three Nominated To ET2; NCI Seeks Clinical Applications

May 24, 1991

Zaltrap Price Cut In Half Effective Immediately

November 8, 2012

Specter Remains Chairman Of Labor-HHS Subcommittee.

February 2, 2001

Analyzing Tumor Tissue In Clinical Trials Can Improve Outcomes, RTOG Trial Finds

May 27, 2011

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

July 17, 2009

Benefits of Mammography Outweigh Harms In Women with Increased Risk, Starting at Age 40

April 27, 2012